Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce a strategic collaboration ...

Nanosecond PFA Cardiac Surgical System for ablation of cardiac tissue to be highlighted in presentation and poster sessions. Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel ...

The NEUROCRINE BIOSCIENCES Logo, NEUROCRINE, YOU DESERVE BRAVE SCIENCE ... the value INGREZZA may bring to patients, and the Company's plans to encourage awareness that may help address the ...

TD is estimated to affect at least 800,000 adults in the U.S. About Neurocrine Biosciences, Inc. The NEUROCRINE BIOSCIENCES Logo ... inhibitor and the Company's plans to encourage awareness ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

The NEUROCRINE BIOSCIENCES Logo, NEUROCRINE and YOU DESERVE BRAVE ... risks and uncertainties associated with Neurocrine Biosciences' business and finances in general, as well as risks and ...

A 30-foot statue? Genetically-modified mammoth? Here is what could be in store for Utah’s NHL team following its rebrand.

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

This drugmaker achieved a milestone - its first quarterly profit. But the stock is down despite the good tidings.